Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care

NCT06660719 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

852

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: SP-8203
DRUG: Placebo

Sponsor

Shin Poong Pharmaceutical Co. Ltd.